Salivary IL-6 levels in oral leukoplakia with dysplasia and its clinical relevance to tobacco habits and periodontitis

[1]  Newell W Johnson,et al.  Betel-quid chewing with or without tobacco is a major risk factor for oral potentially malignant disorders in Sri Lanka: a case-control study. , 2010, Oral oncology.

[2]  J. Wactawski‐Wende,et al.  Chronic Periodontitis and the Incidence of Head and Neck Squamous Cell Carcinoma , 2009, Cancer Epidemiology, Biomarkers & Prevention.

[3]  T. Christoffersen,et al.  A study of phosphorylated ERK1/2 and COX-2 in early stage (T1-T2) oral squamous cell carcinomas. , 2008, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[4]  Y. Konttinen,et al.  Immunohistochemical localization of Toll-like receptors 1-10 in periodontitis. , 2008, Oral microbiology and immunology.

[5]  Hua Yu,et al.  Signal Transducer and Activator of Transcription 3 Is Required for Hypoxia-Inducible Factor-1α RNA Expression in Both Tumor Cells and Tumor-Associated Myeloid Cells , 2008, Molecular Cancer Research.

[6]  M. Navazesh,et al.  Measuring salivary flow: challenges and opportunities. , 2008, Journal of the American Dental Association.

[7]  D. Wong,et al.  Salivary mRNA targets for cancer diagnostics. , 2008, Oral oncology.

[8]  Kuo-Wei Chang,et al.  Expression of phosphorylated Akt in oral carcinogenesis and its induction by nicotine and alkaline stimulation. , 2008, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[9]  M. Karin,et al.  Autocrine IL-6 signaling: a key event in tumorigenesis? , 2008, Cancer cell.

[10]  D. Santini,et al.  IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland. , 2007, The Journal of clinical investigation.

[11]  W. Gerald,et al.  Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas. , 2007, The Journal of clinical investigation.

[12]  J. Brugge,et al.  IL-6 involvement in epithelial cancers. , 2007, The Journal of clinical investigation.

[13]  S. Warnakulasuriya,et al.  Nomenclature and classification of potentially malignant disorders of the oral mucosa. , 2007, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[14]  R. Kurzrock,et al.  Interleukin‐6 and its receptor in cancer , 2007, Cancer.

[15]  J. Siegfried,et al.  Multiple Cytokine and Growth Factor Serum Biomarkers Predict Therapeutic Response and Survival in Advanced-Stage Head and Neck Cancer Patients , 2007, Clinical Cancer Research.

[16]  J. Wactawski‐Wende,et al.  Chronic periodontitis and the risk of tongue cancer. , 2007, Archives of otolaryngology--head & neck surgery.

[17]  E. Rossomando,et al.  Candidate salivary biomarkers associated with alveolar bone loss: cross-sectional and in vitro studies. , 2007, FEMS immunology and medical microbiology.

[18]  A. Milenović,et al.  The significance of salivary interleukin 6 and tumor necrosis factor alpha in patients with oral leukoplakia. , 2006, Oral oncology.

[19]  E. Hurt,et al.  Interleukin 6 supports the maintenance of p53 tumor suppressor gene promoter methylation. , 2005, Cancer research.

[20]  W. Landuyt,et al.  The prognostic value of the hypoxia markers CA IX and GLUT 1 and the cytokines VEGF and IL 6 in head and neck squamous cell carcinoma treated by radiotherapy ± chemotherapy , 2005, BMC Cancer.

[21]  J. Jeng,et al.  The Induction of Prostaglandin E2 Production, Interleukin-6 Production, Cell Cycle Arrest, and Cytotoxicity in Primary Oral Keratinocytes and KB Cancer Cells by Areca Nut Ingredients Is Differentially Regulated by MEK/ERK Activation* , 2004, Journal of Biological Chemistry.

[22]  Carlo Montemagno,et al.  Interleukin 6 and interleukin 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma. , 2004, Archives of otolaryngology--head & neck surgery.

[23]  T. Peters,et al.  Prevalence of oral mucosal lesions in alcohol misusers in south London. , 2004, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[24]  E. Erdemir,et al.  Effects of smoking on clinical parameters and the gingival crevicular fluid levels of IL-6 and TNF-alpha in patients with chronic periodontitis. , 2004, Journal of clinical periodontology.

[25]  G. Powis,et al.  Hypoxia inducible factor as a cancer drug target. , 2003, Current cancer drug targets.

[26]  Y. Ho,et al.  Roles of keratinocyte inflammation in oral cancer: regulating the prostaglandin E2, interleukin-6 and TNF-alpha production of oral epithelial cells by areca nut extract and arecoline. , 2003, Carcinogenesis.

[27]  J. Tanaka,et al.  DNA microarray analysis of human gingival fibroblasts from healthy and inflammatory gingival tissues. , 2003, Biochemical and biophysical research communications.

[28]  J. S. Gutkind,et al.  Epidermal growth factor receptor-independent constitutive activation of STAT3 in head and neck squamous cell carcinoma is mediated by the autocrine/paracrine stimulation of the interleukin 6/gp130 cytokine system. , 2003, Cancer research.

[29]  R. Watson,et al.  Side-Stream Cigarette Smoke Induces Dose–Response in Systemic Inflammatory Cytokine Production and Oxidative Stress , 2002, Experimental biology and medicine.

[30]  C. Streckfus,et al.  Saliva as a diagnostic fluid. , 2002, Oral diseases.

[31]  Razelle Kurzrock,et al.  Autocrine interleukin-6 production in renal cell carcinoma: evidence for the involvement of p53. , 2002, Cancer research.

[32]  D. Weaver,et al.  Autocrine production of interleukin 6 causes multidrug resistance in breast cancer cells. , 2001, Cancer research.

[33]  B. Barton,et al.  IL-6 signaling by STAT3 participates in the change from hyperplasia to neoplasia in NRP-152 and NRP-154 rat prostatic epithelial cells , 2001, BMC Cancer.

[34]  S. Stein,et al.  Regulation of cytokine production in human gingival fibroblasts following treatment with nicotine and lipopolysaccharide. , 2001, Journal of periodontology.

[35]  Z Chen,et al.  Cyclooxygenase regulates human oropharyngeal carcinomas via the proinflammatory cytokine IL‐6: a general role for inflammation? , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[36]  T. Hirano,et al.  Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors , 2000, Oncogene.

[37]  H. Tanzawa,et al.  Genetic aberrations in oral or head and neck squamous cell carcinoma (SCCHN): 1. Carcinogen metabolism, DNA repair and cell cycle control. , 2000, Oral oncology.

[38]  T. Hirano,et al.  Synergistic roles for Pim-1 and c-Myc in STAT3-mediated cell cycle progression and antiapoptosis. , 1999, Immunity.

[39]  W. Kobayashi,et al.  Expression of Tumor Necrosis Factor‐α and Interleukin‐6 in Oral Squamous Cell Carcinoma , 1999, Japanese journal of cancer research : Gann.

[40]  Xiangao Sun,et al.  Hypoxia, but not reoxygenation, induces interleukin 6 gene expression through NF-κB activation , 1997 .

[41]  H Lumerman,et al.  Oral epithelial dysplasia and the development of invasive squamous cell carcinoma. , 1995, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[42]  G. K. Johnson,et al.  Prostaglandin E2 and interleukin-1 levels in smokeless tobacco-induced oral mucosal lesions. , 1994, Journal of periodontal research.

[43]  D. Winn,et al.  Racial differences in risk of oral and pharyngeal cancer: alcohol, tobacco, and other determinants. , 1993, Journal of the National Cancer Institute.

[44]  U. Santhanam,et al.  Repression of the interleukin 6 gene promoter by p53 and the retinoblastoma susceptibility gene product. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[45]  D. B. Ferguson.  Current Diagnostic Uses of Saliva , 1987, Journal of dental research.

[46]  M. Gorsky,et al.  Oral leukoplakia and malignant transformation. A follow‐up study of 257 patients , 1984, Cancer.

[47]  R. Irani,et al.  Incidence rates of oral cancer and natural history of oral precancerous lesions in a 10-year follow-up study of Indian villagers. , 1980, Community dentistry and oral epidemiology.

[48]  M. Brook.  The contribution of dentifrices to oral health: the future. , 1980, Community dentistry and oral epidemiology.

[49]  J. Bánóczy,et al.  Occurrence of epithelial dysplasia in oral leukoplakia. Analysis and follow-up study of 12 cases. , 1976, Oral surgery, oral medicine, and oral pathology.

[50]  T. Eberlein.  Serum Interleukin-6 Level but not Genotype Predicts Survival after Resection in Stages II and III Gastric Carcinoma , 2009 .

[51]  E. Jabłońska,et al.  Serum Levels of IL-lβ, IL-6, TNF-α, sTNF-RI and CRP in Patients with oral cavity cancer , 2008, Pathology & Oncology Research.

[52]  Craig S. Miller,et al.  NF-kappaB dependent cytokine levels in saliva of patients with oral preneoplastic lesions and oral squamous cell carcinoma. , 2005, Cancer detection and prevention.

[53]  Craig S. Miller,et al.  NF-κB dependent cytokine levels in saliva of patients with oral preneoplastic lesions and oral squamous cell carcinoma , 2005 .

[54]  G. Powis,et al.  Hypoxia inducible factor-1alpha as a cancer drug target. , 2004, Molecular cancer therapeutics.

[55]  X. Sun,et al.  Hypoxia, but not reoxygenation, induces interleukin 6 gene expression through NF-kappa B activation. , 1997, Transplantation.

[56]  A. Kimchi,et al.  Interferons and interleukin 6 suppress phosphorylation of the retinoblastoma protein in growth-sensitive hematopoietic cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[57]  University of Southern California School of Dentistry. , 1981, Dental radiography and photography.